Form 4: Ionis Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Eric Swayze, EVP Research of Ionis Pharmaceuticals Inc, sold 53 shares of common stock on October 15, 2026 for $43.54 per share.
Summary
- Option exercise/conversion: acquired 125 Common Stock on October 15, 2026; holds 443 after (Indirect).
- Open-market sale: disposed of 53 Common Stock at $43.54 ($2,308) on October 16, 2026; holds 390 after (Indirect).
- Option exercise/conversion: disposed of 125 Restricted Stock Unit on October 15, 2026; holds 486 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,308 of stock on the open market.
Insider Transactions
Eric Swayze — Officer (EVP Research)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common Stock | 125 | — | — | 443 |
| 2026-10-16 | Open-market sale | Common Stock | 53 | $44 | $2.3K | 390 |
| 2026-10-15 | Option exercise/conversion | Restricted Stock Unit | 125 | — | — | 486 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (125 shares) |
| 2026-10-16 | Open-market sale (53 shares) |
| 2026-10-15 | Option exercise/conversion (125 shares) |
Keywords
insider transaction, Form 4, IONS, IONIS PHARMACEUTICALS INC, bearish, Eric Swayze
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.